Upregulation of Antioxidant Enzymes by ASS234, a Multitarget Directed Propargylamine for Alzheimer's Disease Therapy

類似資料

• In silico assessment of the metabolism and its safety significance of multitarget propargylamine ASS234
  著者:: Ramos, Eva, 等
  出版事項: (2018)
• Wnt Signaling Pathway, a Potential Target for Alzheimer's Disease Treatment, is Activated by a Novel Multitarget Compound ASS234
  著者:: del Pino, Javier, 等
  出版事項: (2014)
• ASS234, As a New Multi-Target Directed Propargylamine for Alzheimer's Disease Therapy
  著者:: Marco-Contelles, José, 等
  出版事項: (2016)
• Highlights of ASS234: a novel and promising therapeutic agent for Alzheimer’s disease therapy
  著者:: Romero, Alejandro, 等
  出版事項: (2019)
• The proof-of-concept of ASS234: Peripherally administered ASS234 enters the central nervous system and reduces pathology in a male mouse model of Alzheimer disease
  著者:: Serrano, Mari Paz, 等
  出版事項: (2017)